MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid
Plasma miRNA expression profiles are heterogenous in patients with PBC with differential responses to UDCA therapy. MiR-126-3p demonstrates predictive potential for a suboptimal response to UDCA in patients with PBC.
Authors
- Jiahe Tian (ORCID: https://orcid.org/0000-0002-5565-3901)
- Jun-Qing Luan
- Zhengsheng Zou (ORCID: https://orcid.org/0000-0002-1778-269X)
- Yuan-feng Shen
- Qin Qiu
- Chaochao Xiong (ORCID: https://orcid.org/0000-0003-3506-6117)
- Szu‐Yu Pan
- Siyu Wang (ORCID: https://orcid.org/0000-0002-7397-6210)
- Yilin Wang (ORCID: https://orcid.org/0000-0002-4432-7545)
- Fusheng Wang (ORCID: https://orcid.org/0000-0002-9369-9361)
- Luo Yang (ORCID: https://orcid.org/0000-0003-0148-8987)
- Xiaomeng Liu (ORCID: https://orcid.org/0000-0002-1212-2772)
- Jia‐Ning Wang (ORCID: https://orcid.org/0000-0003-0135-8832)
- Lifeng Wang (ORCID: https://orcid.org/0000-0002-9209-1004)
- Fanping Meng (ORCID: https://orcid.org/0000-0003-4887-4076)
- Fengyi Li (ORCID: https://orcid.org/0000-0002-2717-4559)
Institutions
- Peking University (CN)
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3748/wjg.v31.i31.109828
- Citations
- 1
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 1.32